News and updates on international.
FIP’s 2026 report identifies gaps in dermatology training, clinical guidance, regulation and remuneration limiting pharmacists’ role in skin health across 51 countries.
Mounjaro is among GLP-1 medicines named in a growing US litigation over sudden vision loss. But court records, regulators and emerging research show that the evidence for tirzepatide remains unsettled.
The WHO and partners have launched a 2026–2030 strategy to strengthen the market for quality-assured childhood cancer medicines, targeting supply shortages, fragmented demand and other barriers affecting access in low- and middle-income countries.
The International Pharmaceutical Federation has adopted a new policy statement calling for stronger pharmacist involvement in medication safety, patient-safety governance, workforce planning, digital health and pharmacovigilance.
Nearly 800 grocery pharmacists in Southern and Central California are voting on a new contract offer from Ralphs and Albertsons, with rejection potentially leading to an unfair labour practice strike.
The International Pharmaceutical Federation has called for stronger support for women and informal carers, urging governments and the pharmacy profession to strengthen pharmacist-led care, medicines education, preventive care and safe transitions of care.
The International Pharmaceutical Federation has adopted new guidance for developing codes of ethics for pharmacists, addressing professional autonomy, wellbeing, patient rights, AI, digital practice and environmental sustainability.
The International Pharmaceutical Federation has called for stronger pharmacist involvement in preventing and reducing harms linked to non-medicinal psychoactive substance use, including early identification, treatment support, overdose prevention and evidence-informed harm reduction.
Global tobacco-leaf production declined by nearly 19% between 2012 and 2024, but Africa recorded an almost 9% increase, while cigarette imports more than doubled, according to a new WHO analysis.
The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma (FDP), the first freeze-dried plasma product approved for use in the United States. Designed for emergency situations where conventional frozen plasma is unavailable, the room-temperature-stable product is expected to enhance trauma care, disaster response, military medicine, and healthcare delivery in remote settings.
Showing 1-10 of 10
